CompletedNot Applicable

Effect of Dexmedetomidine Infusion on Post Anesthesia Discharge Time

Pakistan82 participantsStarted 2023-09-05

Plain-language summary

A randomised control trial evaluating the effect of low dose dexmedetomidine infusion on post anesthesia discharge time in patients of day case breast cancer surgery compared with placebo infusion. The primary outcome was to compare the frequency of early discharge in each group.

Who can participate

Age range18 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18-60 yrs, ASA 1 and 2, elective breast cancer surgery Exclusion Criteria: * BMI greater than 35, CKD stage 3 or greater, known drug allergy to study drug, bradycardia, history of PONV, patients on antiepileptics

What they're measuring

Frequency of early discharge

Timeframe: 120 minutes

Trial details

NCT IDNCT07180810

SponsorShaukat Khanum Memorial Cancer Hospital & Research Centre

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-20

View on ClinicalTrials.gov More Post Anesthesia Discharge Time in Patients of Breast Cancer Surgery trials